Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic

Mise à jour : Il y a 4 ans
Référence : NCT01091662

Femme et Homme

Extrait

This is an 18-week, double-blind, multicenter study with gradual conversion from previous antiepileptic therapy to eslicarbazepine acetate monotherapy in subjects with partial epilepsy.


Critère d'inclusion

  • Epilepsy


Liens